BRÈVE

sur Valsoft Corp

Valsoft Enters the Life Sciences Space with the Acquisition of Anju Software

Montreal-based Valsoft Corporation Inc. has announced the acquisition of Anju Software, a leader in tailored life science solutions for clinical research, medical affairs, and data science. This move marks Valsoft's first foray into the life sciences sector.

Anju Software offers adaptable solutions that simplify life science information management. Their flagship products—TrialMaster, IRMS MAX, and TA Scan—help reduce complexities in drug and device discovery, enhancing patient care.

Laurence P. Birch, CEO of Anju, expressed confidence in the partnership, stating that Valsoft aligns with their long-term vision for growth. Valsoft's CEO, Sam Youssef, echoed this sentiment, praising Anju's track record of global growth and customer satisfaction.

Anju serves a diverse clientele, including pharmaceutical companies, clinical research organizations, and medical device companies. The company's technology facilitates seamless data flow and communication with third-party systems, driving impactful results.

Supported by Valsoft, Anju aims to elevate its market presence while continuing to provide cost-efficient solutions. This acquisition is expected to bolster both companies' capabilities and market reach.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Valsoft Corp